I know I said bye bye! But just wanted to sign in say "Bravo Greece, bravo". The cradle of western civilization may yet be its salvation. "Out of the mouths of babes" as they say. A big Malaka and Cluck U from Socrates
I can find no reference except a 3 year old patent grant. I don't think this has anything to do with ABIO today, but I could be wrong, usually am these days :-(. Can you elaborate on why you think it does or might have significance? TIA
Must be some financial shenanigans involved here because there is no way any institution or deep pocket who didn't have some kind of ulterior motive would shovel more money into this cash burning furnace.
And by then we'll have mechanical hearts anyway. Not sure how they managed to raise money at all, considering how many times this has bounced only to make new lows shortly thereafter. POS, below $1 again at close. Guaranteed! Well, not guaranteed, but I don't see anything getting the in the way of that prediction. Certainly not the lack of news that this 'rally' is based on.
Maybe. You're right about the float. The 'sentiment' around these results should have sent this lower on much, much higher volume. I think the 'failure' of this trial will be up for debate in the coming days. We'll see. Sucks though, the 43% dive I mean. .
Results are skewed and not very useful. The chose the wrong end point. Should have been the more traditional viral load followed by lesions. They targeted an endpoint that is not entirely understood, looking for a huge upside surprise. They got their surprise alright! Ironically, if they had met the endpoint of shedding and missed the viral load and lesions secondaries, the stock would have shot up for no reason. The opposite is happening today IMO. They missed a pointless primary endpoint but hit on the more important and better understood viral load. I don't pretend to understand this all, but seems to me they did not emphasize hitting the more traditional endpoints of viral load and lesions.
Why would they need to? For the time being and into the foreseeable future, cash is not the issue. Irrelevant post, sorry.
Perhaps that's it. Enthusiasm has certainly dissipated since the news, almost as if it didn't happen. But it did. People need confirmation, through a 3rd party, such as an upgrade (by a proper shop, not hacks like Roth or HC Wainright). Not to give GS and that lot any undue credibility, but they do have a large following. Roth and HC are almost a red flag, RDHL would have been better off without them. But ultimately, when they do partner on 105, everybody's confidence will be restored, for a premium.
Thanks for that, appreciated. I am still unnerved at the speed at which all that money, $21M, kind of dissipated. Anyway, NYT today has a front page story online re how odds of surviving a heart attack have vastly improved on just a decade, mostly due to speed to stent.
Mostly just participation in the last secondary, which is fine, but these guys are not fortune tellers, clearly. They are always just on the verge apparently, study after study keeps coming up roses, or so they say, and yet.....secondary follows secondary follows secondary. 34M shares at $0.40 ($13M) in early March which followed 3.1M shares at $1.30 in Nov. $17M raised in the last 8 months. Where is it?